Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services)
$116.76
pos +11.57
+11.00%
Today's Range: 113.22 - 117.94 | EW Avg Daily Volume: 973,600
Last Update: 10/24/14 - 4:06 PM EDT
Volume: 2,819,445
YTD Performance: 59.96%
Open: $113.50
Previous Close: $105.19
52 Week Range: $60.62 - $108.73
Oustanding Shares: 106,033,418
Market Cap: 11,161,077,579
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 10 10
Moderate Buy 0 0 0 0
Hold 6 6 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.71 1.71 1.75 1.67
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 14.99
Price Earnings Comparisons:
EW Sector Avg. S&P 500
14.99 15.00 27.71
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
22.97% 34.62% 43.35%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.41 0.12
Net Income 33.60 0.80 0.21
EPS 38.90 0.83 0.22
Earnings for EW:
EBITDA 0.52B
Revenue 2.05B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.97 $0.92 $3.30 $3.84
Number of Analysts 10 5 12 12
High Estimate $1.03 $0.96 $3.35 $4.02
Low Estimate $0.92 $0.86 $3.26 $3.68
Prior Year $0.91 $0.76 $3.13 $3.30
Growth Rate (Year over Year) 6.26% 20.79% 5.46% 16.21%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishEdwards Lifesciences price target raised at Barclays

Oct 24, 2014 | 7:37 AM EDT

EW price target raised to $92 from $73, said Barclays. 3Q results above consensus on top and bottom line, solidifying an overwhelmingly positive quarter as company continues to take share. Remain equal weight because future compeitition and pricing pressure is likely. 

bullishEdwards Lifesciences numbers boosted at JMP

Aug 21, 2014 | 7:22 AM EDT

Shares of EW now seen reaching $120, according to JMP Securities. Estimates also upped, as growth in the global TAVI market may accelerate. Outperform rating.

By

Jim Cramer

 | Aug 4, 2014 | 11:45 AM EDT

These quality names look appealing on the basis of 30-week moving average.

By

Jim Cramer

 | Jul 30, 2014 | 11:11 AM EDT

Where what the Fed does allegedly determines everything.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

bullishEdwards Lifesciences upgraded at JMP

Jun 11, 2014 | 7:57 AM EDT

EW was upgraded from Market Perform to Outperform, JMP Securities said. $97 price target. Estimates also increased, following positive physician surveys.

By

Jim Cramer

 | Jun 9, 2014 | 6:50 AM EDT

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.

By

Paul Price

 | May 22, 2014 | 9:00 AM EDT

Keep a tally that summarizes all your related holdings: stock, calls and puts.

By

Chris Laudani

 | Apr 15, 2014 | 10:30 AM EDT

Sell into the pop as the good news is set.

bullishEdwards Lifesciences upgraded at JP Morgan

Apr 14, 2014 | 8:12 AM EDT

EW was upgraded from Underweight to Neutral, JP Morgan said. $78 price target. CoreValve injunction has materially altered the industry landscape.

GS has cleared the important hurdle on the way up which increases the odds for an eventual...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher....
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sendin...
Market posting decent day considering Ebola getting headlines again. Believe investors ha...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.